scholarly journals Report from the Usage Dimensions of Open Workgroup

2016 ◽  
Vol 1 ◽  
Author(s):  
Eric Archambault ◽  
Lorcan Dempsey ◽  
Christopher Erdmann ◽  
Stephanie Fulton ◽  
Dee Magnoni ◽  
...  

The Usage Dimensions of Open workgroup came together and considered definitions and priorities around its topic. From priorities, themes were identified. One theme included the character of research outputs and the actual research workflow process. The second theme represented economic considerations. Stakeholders were identified, and solutions consid­ered. Solutions included both short- and long-term actions.OSI2016 Workgroup QuestionWhat are the usage-related challenges currently faced by open efforts? For instance, open data is intriguing in principle, but in reality, making underlying data open can be problematic, con­flicting with the need for research secrecy (whether driven by the desire to be first to publish, or the desire of funders to hold onto data to protect future discovery potential), the potential for misinterpretation by other researchers, and so on. Publishing clinical trial data in open formats is also intriguing but would run afoul of many current consent agreements, particularly older consents. Open access is similarly challenged in some instances by a con­flict between which versions of papers is allowed to appear in open repositories. What is the value of archiving non-final versions? What is the range of issues here, what are the perspec­tives, and what might be some possible solutions?

2016 ◽  
Vol 1 ◽  
Author(s):  
Eric Archambault ◽  
Lorcan Dempsey ◽  
Christopher Erdmann ◽  
Stephanie Fulton ◽  
Dee Magnoni ◽  
...  

What are the usage-related challenges currently faced by open efforts? For instance, open data is intriguing in principle, but in reality, making underlying data open can be problematic, conflicting with the need for research secrecy (whether driven by the desire to be first to publish, or the desire of funders to hold onto data to protect future discovery potential), the potential for misinterpretation by other researchers, and so on. Publishing clinical trial data in open formats is also intriguing but would run afoul of many current consent agreements, particularly older consents. Open access is similarly challenged in some instances by a conflict between which version of papers is allowed appear in open repositories. What is the value of archiving non-final versions? What are the range of issues here, what are the perspectives, and what might be some possible solutions?


2019 ◽  
Vol 95 (2) ◽  
pp. 81-86
Author(s):  
G. A. Vintserskaya ◽  
M. V. Ngema ◽  
D. V. Prokhorov ◽  
M. Yu. Kuznetsova ◽  
Yu. V. Sherengovskaya

The article outlines the questions of pathogenesis of acne as well as clinical trial data, which indicate that the skin of patients with acne needs comprehensive care with therapeutic cosmetics. Long term use of medical cosmetics has a positive effect on the course of acne disease. The basis of the study is the use of cosmetics line A “Skinormil” including the patented complex Citobiol lRIS, zinc sulfate and vitamin A. Seventy-four patients with acne of the first, second and third severity were monitored and it was recommended them a comprehensive skin care with medical cosmetics. According to the analysis of the clinical picture, it was concluded that on the background of proper care, there is a positive dynamics in the course of acne.


1981 ◽  
Vol 3 (3) ◽  
pp. 129-136 ◽  
Author(s):  
T. Ravenscroft ◽  
D.E. Smith

The paper describes the design and implementation of a clinical trial data management system at the Wellcome Research Laboratories. Based on an IBM 3031 computer, the system provides the capability for on-line data input, search ing and comprehensive data analysis. The database also performs an adverse reaction reporting function and provides for long term follow-up of patients.


2014 ◽  
Vol 66 (8) ◽  
pp. 1987-1997 ◽  
Author(s):  
Rieke Alten ◽  
Jeffrey Kaine ◽  
Edward Keystone ◽  
Peter Nash ◽  
Ingrid Delaet ◽  
...  

2019 ◽  
Vol 7 (1) ◽  
pp. 121-131 ◽  
Author(s):  
Paul Emery ◽  
Daniel E. Furst ◽  
Petra Kirchner ◽  
Simone Melega ◽  
Stuart Lacey ◽  
...  

2016 ◽  
Vol 172 ◽  
pp. 64-69 ◽  
Author(s):  
Michael J. Pencina ◽  
Darcy M. Louzao ◽  
Brian J. McCourt ◽  
Monique R. Adams ◽  
Rehbar H. Tayyabkhan ◽  
...  

JAMA ◽  
2016 ◽  
Vol 316 (6) ◽  
pp. 666 ◽  
Author(s):  
Joseph S. Ross ◽  
Harlan M. Krumholz

Sign in / Sign up

Export Citation Format

Share Document